NIH Researchers Discover Novel Class of Anti-Malaria Antibodies - New Antibodies Could Lead to Generation of Interventions ...

Highly pathogenic H5N1 avian influenza A virus (HPAI H5N1) remains a low risk to the general public, and public health ...

Most human cases of bird flu in North America have been mild, a fact that’s underscored by a new study of the first 46 ...

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.

A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...

National Institutes of Health officials assess threat of H5N1: Bethesda, Maryland Friday, January 3, 2025, 16:00 Hrs [IST] Highly pathogenic H5N1 avian influenza A virus (HPAI H5N ...

EDP-235 is under clinical development by Enanta Pharmaceuticals and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

This story, like the virus it is about, continues to evolve. This article summarizes some of the recent findings and opinions related to H5N1 | Microbiology ...

In the wake of Braedyn Bruner’s General Hospital debut as Emma Scorpio-Drake, Brooklyn Rae Silzer took to X to say goodbye to ...

A letter sent to The New England Journal of Medicine and signed by Canadian health officials says the 13-year-old girl ...

Human metapneumovirus (HMPV) is a commonly found virus that can cause respiratory illness. Although the virus typically has ...

New antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody ...